<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Targeted autoimmune therapy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/targeted-autoimmune-therapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Thu, 22 Jan 2026 20:22:09 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Targeted autoimmune therapy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Antibody-Linked Stem Cells Target Autoimmune Diseases</title>
		<link>https://bioengineer.org/antibody-linked-stem-cells-target-autoimmune-diseases/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 22 Jan 2026 20:21:47 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Antibody-conjugated MSCs]]></category>
		<category><![CDATA[autoimmune disease therapy]]></category>
		<category><![CDATA[Cellular immunotherapy]]></category>
		<category><![CDATA[Dual-action immunotherapy** **Açıklama:** 1. **Antibody-conjugated stem cells:** Çalışmanın temel teknolojisini doğrudan tanımlar (MSC'lerin antikorlarla bağlanması). 2]]></category>
		<category><![CDATA[İşte içeriğe uygun 5 etiket: **Antibody-conjugated stem cells]]></category>
		<category><![CDATA[Mesenchymal stromal cell engineering]]></category>
		<category><![CDATA[precision drug delivery]]></category>
		<category><![CDATA[Regenerative Medicine]]></category>
		<category><![CDATA[Targeted autoimmune therapy]]></category>
		<category><![CDATA[targeted drug delivery]]></category>
		<guid isPermaLink="false">https://bioengineer.org/antibody-linked-stem-cells-target-autoimmune-diseases/</guid>

					<description><![CDATA[In a groundbreaking advancement at the crossroads of immunotherapy and regenerative medicine, researchers have unveiled an innovative drug delivery system that harnesses the therapeutic prowess of mesenchymal stromal cells (MSCs) conjugated with antibodies to target autoimmune diseases with unprecedented precision. This pioneering approach, demonstrated in murine models, represents a transformative leap forward in how autoimmune [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">319443</post-id>	</item>
	</channel>
</rss>
